Literature DB >> 31677937

C99 selectively accumulates in vulnerable neurons in Alzheimer's disease.

Maria V Pulina1, Maya Hopkins1, Vahram Haroutunian2,3, Paul Greengard1, Victor Bustos1.   

Abstract

INTRODUCTION: The levels and distribution of amyloid deposits in the brain does not correlate well with Alzheimer's disease (AD) progression. Therefore, it is likely that amyloid precursor protein and its proteolytic fragments other than amyloid b (Ab) contribute to the onset of AD.
METHODS: We developed a sensitive assay adapted to the detection of C99, the direct precursor of b-amyloid. Three postmortem groups were studied: control with normal and stable cognition; patients with moderate AD, and individuals with severe AD. The amount of C99 and Aβ was quantified and correlated with the severity of AD.
RESULTS: C99 accumulates in vulnerable neurons, and its levels correlate with the degree of cognitive impairment in patients suffering from AD. In contrast, Aβ levels are increased in both vulnerable and resistant brain areas. DISCUSSION: These results raise the possibility that C99, rather than Aβ plaques, is responsible for the death of nerve cells in AD.
© 2019 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; Amyloid hypothesis; C99; Proximity-ligation assay; bCTF; β-amyloid

Mesh:

Substances:

Year:  2020        PMID: 31677937     DOI: 10.1016/j.jalz.2019.09.002

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  20 in total

1.  [Progress on loss-of-function hypothesis of presenilin-1 mutations in Alzheimer diseases].

Authors:  Min Yan; Xu Wang; Xihan Guo
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-08-25

Review 2.  The amyloid precursor protein: a converging point in Alzheimer's disease.

Authors:  Alexandré Delport; Raymond Hewer
Journal:  Mol Neurobiol       Date:  2022-05-17       Impact factor: 5.590

Review 3.  Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease.

Authors:  Yuqing Liu; Xin Cheng; Hongli Li; Shan Hui; Zheyu Zhang; Yang Xiao; Weijun Peng
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

4.  A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.

Authors:  Yinan Yao; Seong Su Kang; Yiyuan Xia; Zhi-Hao Wang; Xia Liu; Thorsten Muller; Yi E Sun; Keqiang Ye
Journal:  Brain       Date:  2021-07-28       Impact factor: 13.501

Review 5.  Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?

Authors:  Frédéric Checler; Elissa Afram; Raphaëlle Pardossi-Piquard; Inger Lauritzen
Journal:  J Biol Chem       Date:  2021-03-01       Impact factor: 5.157

6.  Extracellular Sortilin Proteopathy Relative to β-Amyloid and Tau in Aged and Alzheimer's Disease Human Brains.

Authors:  Tian Tu; Juan Jiang; Qi-Lei Zhang; Lily Wan; Ya-Nan Li; Aihua Pan; Jim Manavis; Xiao-Xin Yan
Journal:  Front Aging Neurosci       Date:  2020-05-12       Impact factor: 5.750

7.  The Transcription Factor EB Reduces the Intraneuronal Accumulation of the Beta-Secretase-Derived APP Fragment C99 in Cellular and Mouse Alzheimer’s Disease Models.

Authors:  Anaïs Bécot; Raphaëlle Pardossi-Piquard; Alexandre Bourgeois; Eric Duplan; Qingli Xiao; Abhinav Diwan; Jin-Moo Lee; Inger Lauritzen; Frédéric Checler
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

8.  Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease.

Authors:  Jing Zhang; Na Wu; Shubo Wang; Zitong Yao; Fuchuan Xiao; Jing Lu; Baian Chen
Journal:  Aging Cell       Date:  2021-05-25       Impact factor: 9.304

9.  Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.

Authors:  Claudia P Boix; Inmaculada Lopez-Font; Inmaculada Cuchillo-Ibañez; Javier Sáez-Valero
Journal:  Alzheimers Res Ther       Date:  2020-08-12       Impact factor: 6.982

10.  The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking.

Authors:  Jorge Montesinos; Marta Pera; Delfina Larrea; Cristina Guardia-Laguarta; Rishi R Agrawal; Kevin R Velasco; Taekyung D Yun; Irina G Stavrovskaya; Yimeng Xu; So Yeon Koo; Amanda M Snead; Andrew A Sproul; Estela Area-Gomez
Journal:  EMBO J       Date:  2020-08-31       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.